Office of Disease Prevention and Health Promotion

Search HealthyPeople.gov

Search form

Print Icon Print

You are here

Home » 2020 Topics & Objectives » Blood Disorders and Blood Safety

Blood Disorders and Blood Safety

Expand All Objectives

Hemoglobinopathies

BDBS-1 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive recommended vaccinations
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-2 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies and their families who are referred for evaluation and treatment
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-3 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive care in a patient or family-centered medical home
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-4 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies who receive early and continuous screening for complications
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-5 (Developmental) Increase the proportion of persons with hemoglobinopathies who receive disease-modifying therapies
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-6 (Developmental) Increase the proportion of children with sickle cell disease who receive penicillin prophylaxis from 4 months to 5 years of age
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-7 (Developmental) Reduce hospitalizations due to preventable complications of sickle cell disease among children aged 9 years and under
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Data:
Healthy People 2010 The HP2010 objective with the same definition was 16-21.
Search data for all HP2010 objectives
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-8 (Developmental) Increase the proportion of persons with a diagnosis of hemoglobinopathies who complete high school education or a General Education or Equivalency Diploma (GED) by 25 years of age
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-9 (Developmental) Increase the proportion of community-based organizations (CBOs) that provide outreach and awareness campaigns for hemoglobinopathies
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-10 (Developmental) Increase the proportion of hemoglobinopathy carriers who know their own carrier status
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.

Bleeding and Clotting

BDBS-11 (Developmental) Increase the proportion of persons with bleeding disorders who receive recommended vaccinations
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
Universal Data Collection System (UDC), CDC/NCBDDD
Revision History: History is not available.
BDBS-12 Reduce the number of persons who develop venous thromboembolism (VTE)
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline: 54.3 persons per 10,000 population aged 18 years and older developed venous thromboembolism (VTE) in 2007 (age adjusted to the year 2000 standard population)
Target: 48.9 per 10,000 population
Target-Setting Method: 10 percent improvement
Potential Data Sources:
National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-13 (Developmental) Reduce the number of adults who develop venous thromboembolism (VTE) during hospitalization
BDBS-13.1 (Developmental) Reduce venous thromboembolism (VTE) among adult medical inpatients
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
National Hospital Discharge Survey (NHDS), CDC/NCHS
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-13.2 (Developmental) Reduce venous thromboembolism (VTE) among adult surgical patients
Potential Data Sources:
National Hospital Discharge Survey (NHDS), CDC/NCHS
BDBS-14 (Developmental) Increase the proportion of providers who refer women with symptoms suggestive of inherited bleeding disorders for diagnosis and treatment
Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:
To be determined
Revision History: This objective was archived due to lack of a viable data source. Read more about the revision history.
BDBS-15 Increase the proportion of persons with von Willebrand disease (VWD) seen in specialty care centers who were diagnosed by 21 years of age
Revised

This objective was revised. See Revision History for Details.

Baseline: 69.8 percent of persons with von Willebrand disease (VWD) who were seen in a specialty care center were diagnosed by 21 years of age in 2012
Target: 77.0 percent
Target-Setting Method: 10 percent improvement
Data Sources:
Community Counts Hemophilia Treatment Centers Population Profile (HTC Population Profile), CDC/NCBDDD and ATHN
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Revision History: This objective was revised. Read more about the revision history.
BDBS-16 Reduce the proportion of persons with hemophilia who develop reduced joint mobility due to bleeding into joints
Baseline: 82.9 percent of persons with hemophilia developed reduced joint mobility due to bleeding into joints in 2008
Target: 74.6 percent
Target-Setting Method: 10 percent improvement
Data Sources:
Universal Data Collection System (UDC), CDC/NCBDDD
Data:
Data for this objective HP2020 data for this objective
Data for this objective Spotlight on Disparities:
Data Details Details about the methodology and measurement of this HP2020 objective

Blood Safety

BDBS-17 Increase the proportion of persons who donate blood
Baseline: 6.1 percent of the population aged 18 years and older reported donating blood within the past year in 2008 (age adjusted to the year 2000 standard population)
Target: 6.7 percent
Target-Setting Method: 10 percent improvement
Data Sources:
National Health Interview Survey (NHIS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data for this objective Spotlight on Disparities:
Data Details Details about the methodology and measurement of this HP2020 objective
Healthy People 2010 The HP2010 objective with the same definition was 17-06.
Search data for all HP2010 objectives
BDBS-18 (Developmental) Reduce the proportion of persons who develop adverse events resulting from the use of blood and blood products.
BDBS-18.1 (Developmental) Reduce the proportion of persons who develop adverse events due to transfusion-related acute lung injury (TRALI)
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
BDBS-18.2 (Developmental) Reduce the proportion of persons who develop adverse events due to blood incompatibility
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
BDBS-18.3 (Developmental) Reduce the proportion of persons who develop adverse events due to transfusion-transmitted infections
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
BDBS-18.4 (Developmental) Reduce the proportion of persons who develop adverse events due to alloimmunization among persons with hemoglobinopathies
Potential Data Sources:
Registry and Surveillance in Hemoglobinopathies (RuSH), NIH
BDBS-19 (Developmental) Reduce the proportion of persons who did not receive a transfusion due to a blood product shortage.
BDBS-19.1 (Developmental) Reduce the proportion of persons who did not receive red blood cells due to a blood product shortage
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
BDBS-19.2 (Developmental) Reduce the proportion of persons who did not receive platelets due to a blood product shortage
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
BDBS-19.3 (Developmental) Reduce the proportion of persons who did not receive plasma derivatives due to a blood product shortage
Potential Data Sources:
National Blood Collection and Utilization Survey (NBCUS), DHHS
Back To Top